Increased MAT2A and MAT2B expression occurs in human liver and colon cancers [13] and increased MAT2A expression has also been reported in human gastric cancer [16] and tamoxifen-resistant breast cancer cells [17]. Here, MAT2A is linked to breast carcinoma.